NCT03596658 2022-09-01SHR9549 in ER Positive HER2 Negative Advanced Breast CancerJiangsu HengRui Medicine Co., Ltd.Phase 1 Terminated4 enrolled
NCT02248090 2019-06-24AZD9496 First Time in Patients Ascending Dose StudyAstraZenecaPhase 1 Completed45 enrolled